Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Nucleic Acids Research
|
October 16, 2025
A versatile platform for combinatorial antibody library cloning and NGS-based quality control with high accuracy
Zhongyao Zhang, Simon D'Hondt, Rob Van der Kant, et al.
Biomolecules
|
May 27, 2026
High-Affinity Nanobody Against the LEDGF PWWP Domain Inhibits Chromatin Binding In Vitro
Thibault Vantieghem, Sofie Jansen, Thatcher Zinabu Akele, et al.
Fluids and Barriers of the CNS
|
January 30, 2025
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Marie-Lynn Cuypers, Tom Jaspers, Jarne Clerckx, et al.
Advanced Healthcare Materials
|
June 17, 2024
Microfluidic Interfaces for Chronic Bidirectional Access to the Brain
Simone Marcigaglia, Robin De Plus, Charysse Vandendriessche, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 16, 2025
Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease
Emre Fertan, Jeff Y L Lam, Giulia Albertini, et al.
Frontiers in Oncology
|
October 20, 2022
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model
Kevin Hollevoet, Debby Thomas, Griet Compernolle, et al.
Elife
|
August 18, 2025
A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies
Thomas Balligand, Claire Carpenet, Sergi Olivé Palau, et al.
The Journal of Biological Chemistry
|
May 10, 2023
Selective inhibitors of the PSEN1-gamma-secretase complex
Lutgarde Serneels, Rajeshwar Narlawar, Laura Perez-Benito, et al.
Cancers
|
December 3, 2020
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development
Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, et al.
Nature Neuroscience
|
November 25, 2025
The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia
Giulia Albertini, Magdalena Zielonka, Marie-Lynn Cuypers, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Nucleic Acids Research
|
October 16, 2025
A versatile platform for combinatorial antibody library cloning and NGS-based quality control with high accuracy
Zhongyao Zhang, Simon D'Hondt, Rob Van der Kant, et al.
Biomolecules
|
May 27, 2026
High-Affinity Nanobody Against the LEDGF PWWP Domain Inhibits Chromatin Binding In Vitro
Thibault Vantieghem, Sofie Jansen, Thatcher Zinabu Akele, et al.
Fluids and Barriers of the CNS
|
January 30, 2025
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Marie-Lynn Cuypers, Tom Jaspers, Jarne Clerckx, et al.
Advanced Healthcare Materials
|
June 17, 2024
Microfluidic Interfaces for Chronic Bidirectional Access to the Brain
Simone Marcigaglia, Robin De Plus, Charysse Vandendriessche, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 16, 2025
Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease
Emre Fertan, Jeff Y L Lam, Giulia Albertini, et al.
Frontiers in Oncology
|
October 20, 2022
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model
Kevin Hollevoet, Debby Thomas, Griet Compernolle, et al.
Elife
|
August 18, 2025
A pair of congenic mice for imaging of transplants by positron emission tomography using anti-transferrin receptor nanobodies
Thomas Balligand, Claire Carpenet, Sergi Olivé Palau, et al.
The Journal of Biological Chemistry
|
May 10, 2023
Selective inhibitors of the PSEN1-gamma-secretase complex
Lutgarde Serneels, Rajeshwar Narlawar, Laura Perez-Benito, et al.
Cancers
|
December 3, 2020
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development
Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad, et al.
Nature Neuroscience
|
November 25, 2025
The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia
Giulia Albertini, Magdalena Zielonka, Marie-Lynn Cuypers, et al.
Page
of 3